[go: up one dir, main page]

ES2263147T3 - Transfusion plaquetaria. - Google Patents

Transfusion plaquetaria.

Info

Publication number
ES2263147T3
ES2263147T3 ES93902739T ES93902739T ES2263147T3 ES 2263147 T3 ES2263147 T3 ES 2263147T3 ES 93902739 T ES93902739 T ES 93902739T ES 93902739 T ES93902739 T ES 93902739T ES 2263147 T3 ES2263147 T3 ES 2263147T3
Authority
ES
Spain
Prior art keywords
glycoprotein
ibα
antibody
fragment
met
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93902739T
Other languages
English (en)
Spanish (es)
Inventor
Zaverio M. Ruggeri
Jerry L. Ware
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Application granted granted Critical
Publication of ES2263147T3 publication Critical patent/ES2263147T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)
ES93902739T 1992-01-06 1992-12-23 Transfusion plaquetaria. Expired - Lifetime ES2263147T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US817852 1992-01-06
US07/817,852 US5427939A (en) 1992-01-06 1992-01-06 Expression vectors encoding alloantigens of glycoprotein Ibα

Publications (1)

Publication Number Publication Date
ES2263147T3 true ES2263147T3 (es) 2006-12-01

Family

ID=25224022

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93902739T Expired - Lifetime ES2263147T3 (es) 1992-01-06 1992-12-23 Transfusion plaquetaria.

Country Status (9)

Country Link
US (2) US5427939A (fr)
EP (1) EP0625047B1 (fr)
JP (1) JPH07502744A (fr)
AT (1) ATE325192T1 (fr)
CA (1) CA2127368A1 (fr)
DE (1) DE69233623T2 (fr)
DK (1) DK0625047T3 (fr)
ES (1) ES2263147T3 (fr)
WO (1) WO1993013784A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033774B2 (en) * 1997-04-21 2006-04-25 Glycozyme, Inc. Determination of recombinant glycosylated proteins and peptides in biological fluids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810632A (en) * 1986-12-01 1989-03-07 Scripps Clinic And Research Foundation Cell surface antigen detection method
US4959308A (en) * 1987-08-27 1990-09-25 Board Of Regents, The University Of Texas System Immunoassay for antibodies binding platelets
US5340727A (en) * 1987-11-17 1994-08-23 The Scripps Research Institute GPIbα fragments and recombinant DNA expression vectors
IL88308A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides that block the binding of von willebrand factor

Also Published As

Publication number Publication date
CA2127368A1 (fr) 1993-07-22
US5427939A (en) 1995-06-27
EP0625047A1 (fr) 1994-11-23
US5798216A (en) 1998-08-25
WO1993013784A1 (fr) 1993-07-22
AU673993B2 (en) 1996-12-05
JPH07502744A (ja) 1995-03-23
AU3440193A (en) 1993-08-03
DE69233623D1 (de) 2006-06-08
ATE325192T1 (de) 2006-06-15
DK0625047T3 (da) 2006-09-11
EP0625047B1 (fr) 2006-05-03
DE69233623T2 (de) 2007-05-10
EP0625047A4 (en) 1995-12-13

Similar Documents

Publication Publication Date Title
Zwirner et al. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients
EP0326595B1 (fr) Peptides et anticorps empechant l'adherence de plaquettes
US5306620A (en) Antibodies that bind to a ligand-induced binding site on integrin and induce integrin activation
Schulte am Esch et al. Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor
Broberg et al. GpIIb/IIIa is the main receptor for initial platelet adhesion to glass and titanium surfaces in contact with whole blood
EA012872B1 (ru) АНТИТЕЛА ПРОТИВ MAdCAM
JP3186765B2 (ja) 血小板凝集疾患の特徴付け
Hofer et al. Ig‐like transcript 4 as a cellular receptor for soluble complement fragment C4d
Asch et al. Identification and isolation of a platelet GPIb-like protein in human umbilical vein endothelial cells and bovine aortic smooth muscle cells.
PT100235B (pt) Proteinas receptores da superficie celular analogos polipeptidicos dos factores de coagulacao v e viii, anticorpos para os mesmos, moleculas de adn, processo para analise da presenca de um receptor da superficie celular e processo para controlar a resposta de um paciente
US7622557B2 (en) Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (BCRP)
ES2263147T3 (es) Transfusion plaquetaria.
AU2001263496A1 (en) Method of identifying and/or isolating stem cells and prognosing responsiveness to leukemia treatment
AU673993C (en) Platelet transfusion
Sachs et al. A point mutation in the EGF-4 domain of β3 integrin is responsible for the formation of the Seca platelet alloantigen and affects receptor function
Cauwenberghs et al. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction
Stephenson et al. Genetics of the rat CT system: its apparent complexity is a consequence of cross‐reactivity between the distinct MHC class I antigens RT1. C and RT1. A
ES2319386T3 (es) Proteina 2 del canal del calcio de tipo trp (tlcc-2) humana.
Smith et al. Characterization of a new hereditary thrombopathy in a closed colony of Wistar rats
Ye The role of syntaxin and tomosyn in platelet secretion
Jaques Anti-CD4 induced transplantation tolerance in the rat: molecular and cellular mechanisms
Neely Molecular mechanisms in allergic asthma and brain edema
Crombie Lysosomal integral membrane protein II, a member of the CD36 gene family: Comparative analysis of structure-function relationships
Schmeissner The role of integrins in T cell development
AU2130188A (en) Peptides and antibodies that inhibit platelet adhesion